Paper41377933
mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics.
Yang B and 3 others. Cancer Innov, 2025. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics. Papers, record 41377933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41377933
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References190
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32728218 | An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma. | Nature | 2020 | https://conductscience.org/library/papers/32728218 | PubMed |
| 2 | 34266884 | Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/34266884 | PubMed |
| 3 | 36151112 | Payload distribution and capacity of mRNA lipid nanoparticles. | Nat Commun | 2022 | https://conductscience.org/library/papers/36151112 | PubMed |
| 4 | 38142147 | The potential of mRNA vaccines in cancer nanomedicine and immunotherapy. | Trends Immunol | 2024 | https://conductscience.org/library/papers/38142147 | PubMed |
| 5 | 35224304 | Blockading a new NSCLC immunosuppressive target by pluripotent autologous tumor vaccines magnifies sequential immunotherapy. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35224304 | PubMed |
| 6 | 40336841 | O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment. | Front Cell Neurosci | 2025 | https://conductscience.org/library/papers/40336841 | PubMed |
| 7 | 39849594 | WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome. | J Hematol Oncol | 2025 | https://conductscience.org/library/papers/39849594 | PubMed |
| 8 | 38890171 | Expression of the tumor antigens NY-ESO-1, tyrosinase, MAGE-A3, and TPTE in pediatric and adult melanoma: a retrospective case control study. | Virchows Arch | 2024 | https://conductscience.org/library/papers/38890171 | PubMed |
| 9 | 38715363 | Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies. | Mol Ther | 2024 | https://conductscience.org/library/papers/38715363 | PubMed |
| 10 | 37652091 | A review on PLGA particles as a sustained drug-delivery system and its effect on the retina. | Exp Eye Res | 2023 | https://conductscience.org/library/papers/37652091 | PubMed |
| 11 | 39387241 | Discovery of Ketal-Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/39387241 | PubMed |
| 12 | 40348781 | Proteome-wide determinants of co-translational chaperone binding in bacteria. | Nat Commun | 2025 | https://conductscience.org/library/papers/40348781 | PubMed |
| 13 | 40185331 | Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activation. | J Control Release | 2025 | https://conductscience.org/library/papers/40185331 | PubMed |
| 14 | 39731215 | Revolutionising Cancer Immunotherapy: Advancements and Prospects in Non-Viral CAR-NK Cell Engineering. | Cell Prolif | 2025 | https://conductscience.org/library/papers/39731215 | PubMed |
| 15 | 39737597 | Transfection Potency of Lipid Nanoparticles Containing mRNA Depends on Relative Loading Levels. | ACS Appl Mater Interfaces | 2025 | https://conductscience.org/library/papers/39737597 | PubMed |
| 16 | 37117161 | Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37117161 | PubMed |
| 17 | 39798545 | Clinical advances of mRNA vaccines for cancer immunotherapy. | Med | 2025 | https://conductscience.org/library/papers/39798545 | PubMed |
| 18 | 40629076 | Eliciting antitumor immunity via therapeutic cancer vaccines. | Cell Mol Immunol | 2025 | https://conductscience.org/library/papers/40629076 | PubMed |
| 19 | 35595777 | Codon-specific Ramachandran plots show amino acid backbone conformation depends on identity of the translated codon. | Nat Commun | 2022 | https://conductscience.org/library/papers/35595777 | PubMed |
| 20 | 39015802 | Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade. | Mater Today Bio | 2024 | https://conductscience.org/library/papers/39015802 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42888436 | The advances and challenges of mRNA-LNP application in fields of hematology and oncology therapeutics. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42888436 | PubMed |
| 42877411 | Gene therapy for non-obstructive azoospermia: therapeutic avenues and translational pathway to clinical application. | Front Genome Ed | 2026 | https://conductscience.org/library/papers/42877411 | PubMed |
| 42782773 | mRNA Vaccines as Novel Immunotherapeutic Approaches in Gastrointestinal Cancers. | Cells | 2026 | https://conductscience.org/library/papers/42782773 | PubMed |
| 42765443 | mRNA Therapeutics Beyond Infectious Diseases: Expanding Therapeutic Applications and Future Perspectives. | Immun Inflamm Dis | 2026 | https://conductscience.org/library/papers/42765443 | PubMed |
| 42565117 | Beyond the genetic code: orchestrating epigenetic and immune landscapes with multivalent mRNA-exosome vaccines. | Precis Clin Med | 2026 | https://conductscience.org/library/papers/42565117 | PubMed |
| 42482783 | mRNA cancer vaccines: delivery strategies, immune modulation, and clinical translation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42482783 | PubMed |
| 42380060 | Toward the Era of Precision Immunotherapy: The Clinical Landscape and Future Directions of mRNA Vaccines for the Treatment of Hepatocellular Carcinoma. | J Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42380060 | PubMed |
| 42174288 | Preserving the future of vaccine science in the USA. | Nat Microbiol | 2026 | https://conductscience.org/library/papers/42174288 | PubMed |
| 42052515 | Nanotechnology-Assisted Co-Delivery of Immunotherapeutic Agents for Targeting Ovarian Cancer: Prospects and Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42052515 | PubMed |
| 41971684 | mRNA vaccines in oncology: personalized cancer immunization and neoantigen targeting. | Mol Cell Oncol | 2026 | https://conductscience.org/library/papers/41971684 | PubMed |
| 41893758 | Circular RNA as a New Vaccine Platform: Considerations, Challenges, and Perspectives. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893758 | PubMed |
| 41377933 | mRNA Cancer Vaccines: From Pandemic Paradigm to Personalized Oncology Therapeutics. | Cancer Innov | 2025 | https://conductscience.org/library/papers/41377933 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41377933
GET https://conductscience.org/api/papers/v1/41377933/references?page=2